$MDAI Income Statement | Understand Stock

$MDAI

$1.53 +$0.03 (2.0%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Research and development revenue
Cost of revenue
Gross profit
Operating costs and expenses:
General and administrative
Total operating costs and expenses
Operating loss
Other income (expense):
Net interest income
Borrowing related costs
Net interest (expense) income
Financing related costs
Amortization of debt discount
Change in fair value of warrant liabilities
Transaction costs allocated to warrant liabilities
Change in fair value of notes payable
Foreign exchange transaction loss, net
Transaction costs
Other expenses, including transaction costs
Total other income (expense), net

Loss before income taxes
Income tax provision
Net income (loss)
Weighted average shares outstanding (in Shares)
Common Class A
Common Class B
Basic and diluted net income loss per share (in Dollars per share)
Net loss
Net loss per share of common stock
Basic (in Dollars per share)
Common Class A
Common Class B
Total basic (in Dollars per share)

Diluted (in Dollars per share)
Common Class A
Common Class B
Total diluted (in Dollars per share)

Weighted-average common shares outstanding
Basic (in Shares)
Common Class A
Common Class B
Total basic (in Shares)

Diluted (in Shares)
Common Class A
Common Class B
Total diluted (in Shares)

Other comprehensive income:
Foreign currency translation adjustments
Total comprehensive loss

Comments